Women’s Health
R-Biopharm Australia provides advanced vaginal microbiome testing solutions for the comprehensive assessment of vaginal microbiota, bacterial vaginosis, vulvovaginal candidiasis and other causes of vaginal dysbiosis. Using highly sensitive multiplex PCR technology, our molecular diagnostic panels enable rapid, accurate analysis of the vaginal microbiome by measuring the relative abundance of key bacterial species while simultaneously detecting clinically significant fungal and parasitic pathogens. By differentiating healthy Lactobacillus-dominant flora from intermediate disturbances and established dysbiosis, our assays provide valuable diagnostic insights that support informed clinical decision-making and improved patient management. Combined with automated extraction solutions and integrated PCR technology, our women’s health diagnostics deliver an efficient end-to-end workflow for modern hospital pathology and clinical microbiology laboratories.
Understanding the Vaginal Microbiome
A healthy vaginal microbiome plays an important role in maintaining reproductive health and protecting against infection. Changes in the balance of beneficial and pathogenic microorganisms can contribute to conditions such as bacterial vaginosis, vulvovaginal candidiasis and other vaginal infections. R-Biopharm Australia’s multiplex PCR vaginal microbiome testing solutions provide comprehensive analysis of vaginal microbiota, enabling clinical laboratories to assess microbial balance while accurately detecting clinically significant pathogens from a single sample. This detailed molecular insight supports more confident diagnosis and appropriate patient management in women’s health diagnostics.
Vaginal Microbiome Testing Portfolio
BV & Thrush
Panels for determining the bacterial balance between normal and anaerobic flora, detection of the most common Candida species, and detection of Trichomonas vaginalis.
Bacteria
- Atopobium vaginae
- Gardnerella vaginalis
- Lactobacillus crispatus
- Lactobacillus iners
Fungi
- Candida albicans
- Candida parapsilosis
- Nakaseomyces glabratus (formerly Candida glabrata)
- Pichia kudriavzevii (formerly Candida krusei)
Parasites
- Trichomonas vaginalis
Ordering Information
| Ref | Description | Pack Size | Tests |
|---|---|---|---|
| 27117S | RIDA®Plex Vaginitis and Vaginosis 8 well Step 1 | 12 x 8-well Strips | 96 |
| 27117P | RIDA®Plex Vaginitis and Vaginosis 8 well Step 2 | 12 x 384-well Plates | 288 |
| 40241 | RIDA®Plex S DNA Cassette | 10 Cassettes | – |
| 91021 | RIDA®Plex Positive Control STIs and Herpes | 10 x 2mL Tubes | – |
Bacteria
- Atopobium vaginae
- Gardnerella vaginalis
- Lactobacillus crispatus
- Lactobacillus gasserii
- Lactobacillus iners
- Lactobacillus jensenii
- Lactobacillus johnsonii
Fungi
- Candida albicans
- Candida tropicalis
- Candida parapsilosis
- Nakaseomyces glabratus (formerly Candida glabrata)
- Pichia kudriavzevii (formerly Candida krusei)
Parasites
- Trichomonas vaginalis
Ordering Information
| Ref | Description | Pack Size | Tests |
|---|---|---|---|
| 87124S | RIDA®Plex Vaginitis and Vaginosis 12 well Step 1 | 12 x 8-well Strips | 96 |
| 87124P | RIDA®Plex Vaginitis and Vaginosis 12 well Step 2 | 12 x 384-well Plates | 288-384^ |
| 40231 | RIDA®Plex L DNA Cassette* | 10 Cassettes | – |
| 40631 | RIDA®Plex S DNA Reservoir** | 4 Reservoirs | – |
| 40621 | RIDA®Plex M DNA Reservoir** | 4 Reservoirs | – |
| 40611 | RIDA®Plex L DNA Reservoir** | 4 Reservoirs | – |
| 91021 | RIDA®Plex Positive Control STIs and Herpes | 10 x 2mL Tubes | – |
^ Step 2 plates allow for up to 288 tests on RIDA®Xplore, up to 384 tests on RIDA®Jump.
* Reagent Cassettes are for use with the RIDA®Xplore.
** Reagent Reservoirs are for use with the RIDA®Jump.
Designed for Clinical Laboratories
Our vaginal microbiome testing solutions are designed for hospital pathology laboratories, women’s health laboratories, clinical microbiology laboratories and reference laboratories requiring comprehensive assessment of vaginal microbiota and infectious causes of vaginitis. Using advanced multiplex PCR technology, our assays simultaneously analyse the balance between beneficial Lactobacillus species and anaerobic bacteria while detecting clinically significant pathogens including Candida species and Trichomonas vaginalis. This comprehensive molecular approach provides faster, more objective results than traditional microscopy and culture, supporting accurate diagnosis of bacterial vaginosis, vulvovaginal candidiasis and vaginal dysbiosis.
By delivering detailed insights into vaginal microbial composition, our molecular diagnostic solutions improve laboratory efficiency, increase diagnostic confidence and support more targeted treatment decisions for women’s health conditions.
Explore Our Technology
Our vaginal microbiome testing portfolio combines automated nucleic acid extraction (RIDA®Xtract 24 & RIDA®Xtract 96), advanced multiplex PCR instrumentation (RIDA®Xplore & RIDA®Jump) and integrated molecular diagnostic workflows to deliver rapid assessment of vaginal microbiota and detection of clinically significant pathogens. Designed for modern clinical laboratories, these solutions reduce hands-on time, improve throughput and provide fast, reliable results that support accurate diagnosis of bacterial vaginosis, vaginitis and vaginal dysbiosis.
RIDA®Plex IVD panels are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European IVD Directive 98/79/EC. In the USA: For Research Use Only (RUO). For Research Use Only (RUO), not for use In diagnostic procedures. RIDA®Plex RUO panels are for Research Use Only in any jurisdiction.
